Efficacy and safety of monoclonal antibodies targeting interleukin-5 and interleukin-4/13 pathways in eosinophilic myocarditis: a single-center experience.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Translating improved disease understanding to novel therapies in myocardial disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by